Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma

Medical Oncology
Kazuhiro Yamamoto, Ikuko Yano

Abstract

The prognosis of patients with metastatic renal cell carcinoma has drastically improved due to the development of molecular-targeted drugs and their use in clinical practice. However, these drugs cause some diverse adverse reactions in patients and sometimes affect clinical outcomes of cancer therapy. Therefore, predictive markers are necessary to avoid severe adverse reactions, to establish novel and effective prevention methods, and to improve treatment outcomes. Some genetic factors involved in these adverse reactions have been reported; however, perspectives on each adverse response have not been integrated yet. In this review, genetic polymorphisms relating to molecular-targeted therapy-induced adverse reactions in patients with renal cell carcinoma are summarized in the points of pharmacokinetic and pharmacodynamic mechanisms. We also discuss about the relationship between systemic drug exposure and adverse drug reactions.

References

Nov 2, 1995·The New England Journal of Medicine·P J BosmaR P Oude Elferink
Dec 1, 1994·Carcinogenesis·F CroftsS J Garte
Oct 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·S D ZuckerK E Sherman
Oct 3, 2002·American Journal of Respiratory and Critical Care Medicine·Surendra K SharmaNarinder K Mehra
Aug 18, 2005·Journal of Gastroenterology and Hepatology·John K OlynykLawrie W Powell
Jan 12, 2007·The New England Journal of Medicine·Bernard EscudierUNKNOWN TARGET Study Group
Jun 1, 2007·The New England Journal of Medicine·Gary HudesUNKNOWN Global ARCC Trial
Aug 8, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·James E NelsonKris V Kowdley
Aug 21, 2007·Journal of the American College of Cardiology·Yibo WangRutai Hui
Jun 2, 2009·Nature Genetics·Ann K DalyUNKNOWN International SAE Consortium
Jun 3, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert J MotzerRobert A Figlin
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nielka P van ErpHans Gelderblom
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shuiying HuSharyn D Baker
Jan 27, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cora N SternbergRobert E Hawkins
Jul 16, 2010·Journal of Experimental & Clinical Cancer Research : CR·Lokesh JainWilliam D Figg
Oct 23, 2010·Japanese Journal of Clinical Oncology·Taiji TsukamotoHideyuki Akaza
Nov 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Astrid A M van der VeldtJudith A M Wessels
Apr 1, 2011·Clinical Pharmacology and Therapeutics·R M FrankeA Sparreboom
Feb 7, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Cody J PeerWilliam D Figg
Feb 14, 2012·Investigational New Drugs·Roger B Cohen, Stéphane Oudard
Jun 8, 2012·Drug Metabolism and Pharmacokinetics·Tomoyuki MizunoToshiya Katsura
Jun 16, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A PoprachUNKNOWN Czech Renal Cancer Cooperative Group
Jan 24, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric I ZimmermanSharyn D Baker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.